LPCN Next Earnings Date Notes

— Lipocine Inc. (LPCN) is a clinical-stage biopharmaceutical company focused on developing innovative oral therapies for metabolic and endocrine disorders, with a primary emphasis on conditions related to testosterone deficiency, nonalcoholic steatohepatitis (NASH), and central nervous system (CNS) disorders. The company's most well-known asset is TLANDO, an oral testosterone replacement therapy that has received FDA approval, while several other candidates (such as LPCN 1144 for NASH and LPCN 1154 for postpartum depression) remain in various stages of clinical development or regulatory review. For long-term performance, investors should closely track pipeline progress & regulatory milestones (FDA submissions, approvals, & trial readouts), licensing or partnership deals (which can provide both up-front payments & ongoing royalties), and the pace of TLANDO commercialization—especially revenue growth, prescription trends, & market penetration. On earnings calls, management’s updates about cash runway, R&D expenses, and strategies for advancing & monetizing the pipeline are crucial for assessing the company's financial stability and growth prospects. The next projected earnings date for LPCN is 11/5/2026 8:00 am (stay tuned for a confirmed earnings date once announced).

LPCN Next Earnings Date FAQ

On this page we presented the LPCN Next Earnings Date information for Lipocine along with recent past earnings dates. For Q2 of 2026, LPCN reported earnings of -0.320/share, with the earnings report taking place on 8/4/2026. For Q1 of 2026, LPCN reported earnings of -0.540/share, with the earnings report taking place on 5/7/2026. For Q4 of 2025, LPCN reported earnings of -0.340/share, with the earnings report taking place on 3/10/2026. For Q3 of 2025, LPCN reported earnings of -0.590/share, with the earnings report taking place on 11/6/2025. For Q2 of 2025, LPCN reported earnings of -0.410/share, with the earnings report taking place on 8/5/2025. Based on these past earnings dates, the projected next earnings date for LPCN is 11/5/2026 8:00 am.

Any self directed investor who desires to keep tabs on the companies they own, can benefit from maintaining a calendar of next earnings dates for each stock in their porfolio, such as Lipocine. When a company files its 10Q's with the SEC a mere four times a year, that certainly puts a lot of pressure on those four out of three hundred sixty five days! To say that earnings reports are important to Lipocine shareholders would thus be an understatement! That's why we started the NextEarningsDate.com website, to make it easy for self directed investors to research Lipocine next earnings dates as well as any other stock out there in our coverage universe, to see when the next LPCN earnings date — or any other stock — falls on the calendar. But we also present considerably more than just the next earnings date information alone, so we encourage you to explore the additional pages linked above to look up LPCN's past earnings as well, with pages for revenue and earnings history data, as well as earnings surprises as well. Thanks for visiting, and we hope you'll think of our site the next time you need to learn about the LPCN next earnings date.